Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (DIC) with theophylline (THP) were obtained, and their crystal structures were determined. In both of the crystal structures, molecules form a hydrogen bonded supramolecular unit consisting of a centrosymmetric dimer of THP and two molecules of active pharmaceutical ingredient (API). Crystal lattice energy calculations showed that the packing energy gain of the [DIC + THP] cocrystal is derived mainly from the dispersion energy, which dominates the structures of the cocrystals. The enthalpies of cocrystal formation were estimated by solution calorimetry, and their thermal stability was studied by differential scanning calorimetry. The cocrystals...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
This work reports two novel drug–drug cocrystals of antifungal clotrimazole (CLT) with nonsteroidal ...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
Cocrystallization of nonsteroidal anti-inflammatory drug fenamates (<i>N</i>-phenylanthranilic acid ...
The design and synthesis of stable solid-state pharmaceutical cocrystals of diuretic drug furosemide...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Pharmaceutical cocrystals, which contain at least one active pharmaceutical ingredient (API), are st...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
A thermodynamic based approach is used to investigate diflunisal + nicotinamide binary and solution ...
Co-crystals between drug molecules and coformers have shown great potential to optimize the stabilit...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
This work reports two novel drug–drug cocrystals of antifungal clotrimazole (CLT) with nonsteroidal ...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
In the last years, the design and synthesis of co-crystals containing active pharmaceutical ingredi...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
Cocrystallization of nonsteroidal anti-inflammatory drug fenamates (<i>N</i>-phenylanthranilic acid ...
The design and synthesis of stable solid-state pharmaceutical cocrystals of diuretic drug furosemide...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Pharmaceutical cocrystals, which contain at least one active pharmaceutical ingredient (API), are st...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
A thermodynamic based approach is used to investigate diflunisal + nicotinamide binary and solution ...
Co-crystals between drug molecules and coformers have shown great potential to optimize the stabilit...
The primary aim of pharmaceutical materials engineering is the successful formulation and process de...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...